Robenacoxib versus meloxicam for the control of peri-operative pain and inflammation associated with orthopaedic surgery in cats: a randomised clinical trial

Table 1 Treatment groups

Groups	Number of cats	s.c. dosage (mean ± SD) in mg/kg		Daily oral dosage (mean ± SD) in mg/kg*
Groups	Number of cats	Target	Actual	Target	Actual
Robenacoxib (s.c. + oral)	101	2.0	2.0 ± 0.09	1.0 – 2.4	1.58 ± 0.41
Meloxicam (s.c. + placebo oral)	46	0.3	0.3 ± 0.005	-	-

s.c.: subcutaneous.
*Robenacoxib and placebo tablets were administered once daily for 9 (range, 7–11) days.

ISSN: 1746-6148